Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Pancreatitis

Free Subscription Articles published in Gut Retrieve available abstracts of 148 articles: HTML format

Single Articles

July 2021
1. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
   Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
   Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
   PubMed     Abstract available
   
   
   June 2021
2. POTJER TP
   Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?
   Gut. 2021 Jun 18. pii: gutjnl-2021-324739. doi: 10.1136/gutjnl-2021-324739.
   PubMed    
   
   
   
3. LV XH, Deng K, Yang JL
   Duality of the association between COVID-19 and acute pancreatitis.
   Gut. 2021 Jun 15. pii: gutjnl-2021-325221. doi: 10.1136/gutjnl-2021-325221.
   PubMed    
   
   
   May 2021
4. KOSCHNY R, Lang M, Hackert T
   Enormously dilated pancreatic duct.
   Gut. 2021 May 7. pii: gutjnl-2021-324335. doi: 10.1136/gutjnl-2021-324335.
   PubMed    
   
   
   
5. GENIN E, Cooper DN, Masson E, Ferec C, et al
   NGS mismapping confounds the clinical interpretation of the PRSS1 p.Ala16Val (c.47C>T) variant in chronic pancreatitis.
   Gut. 2021 May 7. pii: gutjnl-2021-324943. doi: 10.1136/gutjnl-2021-324943.
   PubMed    
   
   
   April 2021
6. CHANDRA V, McAllister F
   Therapeutic potential of microbial modulation in pancreatic cancer.
   Gut. 2021 Apr 27. pii: gutjnl-2019-319807. doi: 10.1136/gutjnl-2019-319807.
   PubMed    
   
   
   
7. HACKENG WM, Brosens LAA, Kim JY, O'Sullivan R, et al
   Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
   Gut. 2021 Apr 13. pii: gutjnl-2020-322595. doi: 10.1136/gutjnl-2020-322595.
   PubMed     Abstract available
   
   
   
8. KLOESCH B, Ionasz V, Paliwal S, Hruschka N, et al
   A GATA6-centred gene regulatory network involving HNFs and DeltaNp63 controls plasticity and immune escape in pancreatic cancer.
   Gut. 2021 Apr 12. pii: gutjnl-2020-321397. doi: 10.1136/gutjnl-2020-321397.
   PubMed     Abstract available
   
   
   
9. XIE Z, Gao Y, Ho C, Li L, et al
   Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
   Gut. 2021 Apr 7. pii: gutjnl-2020-323014. doi: 10.1136/gutjnl-2020-323014.
   PubMed     Abstract available
   
   
   
10. OVERBEEK KA, Levink IJM, Koopmann BDM, Harinck F, et al
    Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Gut. 2021 Apr 5. pii: gutjnl-2020-323611. doi: 10.1136/gutjnl-2020-323611.
    PubMed     Abstract available
    
    
    March 2021
11. GLEESON FC, Jeraldo P, Levy MJ, Murphy SJ, et al
    Composition, diversity and potential utility of intervention-naive pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324031. doi: 10.1136/gutjnl-2021-324031.
    PubMed    
    
    
    
12. ZHOU T, Liu J, Xie Y, Yuan S, et al
    ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
    Gut. 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
    PubMed     Abstract available
    
    
    
13. KOLODKIN-GAL D, Roitman L, Ovadya Y, Azazmeh N, et al
    Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
    Gut. 2021 Mar 1. pii: gutjnl-2020-321112. doi: 10.1136/gutjnl-2020-321112.
    PubMed     Abstract available
    
    
    February 2021
14. TACELLI M, Zaccari P, Capurso G, Arcidiacono PG, et al
    Artificial intelligence in EUS for autoimmune pancreatitis: bias and real life.
    Gut. 2021 Feb 22. pii: gutjnl-2021-324338. doi: 10.1136/gutjnl-2021-324338.
    PubMed    
    
    
    
15. SUN X, He X, Zhang Y, Hosaka K, et al
    Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
    Gut. 2021 Feb 10. pii: gutjnl-2020-322744. doi: 10.1136/gutjnl-2020-322744.
    PubMed     Abstract available
    
    
    
16. PANDANABOYANA S, Moir J, Leeds JS, Oppong K, et al
    SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
    Gut. 2021 Feb 5. pii: gutjnl-2020-323364. doi: 10.1136/gutjnl-2020-323364.
    PubMed     Abstract available
    
    
    
17. ADAM MG, Beyer G, Christiansen N, Kamlage B, et al
    Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects.
    Gut. 2021 Feb 4. pii: gutjnl-2020-320723. doi: 10.1136/gutjnl-2020-320723.
    PubMed     Abstract available
    
    
    January 2021
18. LUCHINI C, Grant RC, Scarpa A, Gallinger S, et al
    Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
    Gut. 2021 Jan 19. pii: gutjnl-2020-323805. doi: 10.1136/gutjnl-2020-323805.
    PubMed    
    
    
    November 2020
19. RANA SS, Gupta R
    Walled of necrosis, disconnected pancreatic duct and metal stents: the debate continues!
    Gut. 2020 Nov 9. pii: gutjnl-2020-323190. doi: 10.1136/gutjnl-2020-323190.
    PubMed    
    
    
    
20. FROST F, Kacprowski T, Ruhlemann M, Pietzner M, et al
    Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
    Gut. 2020 Nov 9. pii: gutjnl-2020-322753. doi: 10.1136/gutjnl-2020-322753.
    PubMed     Abstract available
    
    
    
21. KEMPENEERS MA, Issa Y, Verdonk RC, Bruno M, et al
    Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study.
    Gut. 2020 Nov 6. pii: gutjnl-2020-322117. doi: 10.1136/gutjnl-2020-322117.
    PubMed     Abstract available
    
    
    October 2020
22. SANO M, Takahashi R, Ijichi H, Ishigaki K, et al
    Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
    Gut. 2020 Oct 21. pii: gutjnl-2020-320608. doi: 10.1136/gutjnl-2020-320608.
    PubMed     Abstract available
    
    
    
23. MARYA NB, Powers PD, Chari ST, Gleeson FC, et al
    Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Gut. 2020 Oct 7. pii: gutjnl-2020-322821. doi: 10.1136/gutjnl-2020-322821.
    PubMed     Abstract available
    
    
    
24. 
    Correction: Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Gut. 2020;69:e6.
    PubMed    
    
    
    
25. DIAFERIA GR, Natoli G
    Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322814. doi: 10.1136/gutjnl-2020-322814.
    PubMed    
    
    
    September 2020
26. WEISS FU, Laemmerhirt F, Lerch MM
    Next generation sequencing pitfalls in diagnosing trypsinogen (PRSS1) mutations in chronic pancreatitis.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322864. doi: 10.1136/gutjnl-2020-322864.
    PubMed    
    
    
    
27. BARRETO SG, Habtezion A, Gukovskaya A, Lugea A, et al
    Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322163. doi: 10.1136/gutjnl-2020-322163.
    PubMed     Abstract available
    
    
    
28. GRANT RC, Denroche R, Jang GH, Nowak KM, et al
    Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
    Gut. 2020 Sep 15. pii: gutjnl-2020-320730. doi: 10.1136/gutjnl-2020-320730.
    PubMed     Abstract available
    
    
    
29. YOUNG K, Lawlor RT, Ragulan C, Patil Y, et al
    Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
    Gut. 2020 Sep 3. pii: gutjnl-2020-321016. doi: 10.1136/gutjnl-2020-321016.
    PubMed     Abstract available
    
    
    
30. GOUT J, Perkhofer L, Morawe M, Arnold F, et al
    Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
    Gut. 2020 Sep 1. pii: gutjnl-2019-319970. doi: 10.1136/gutjnl-2019-319970.
    PubMed     Abstract available
    
    
    
31. VAN DEN BERG FF, van Dalen D, Hyoju SK, van Santvoort HC, et al
    Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate.
    Gut. 2020 Sep 1. pii: gutjnl-2019-320430. doi: 10.1136/gutjnl-2019-320430.
    PubMed     Abstract available
    
    
    August 2020
32. PERKHOFER L, Gout J, Roger E, Kude de Almeida F, et al
    DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives.
    Gut. 2020 Aug 27. pii: gutjnl-2019-319984. doi: 10.1136/gutjnl-2019-319984.
    PubMed     Abstract available
    
    
    
33. CAMOLOTTO SA, Belova VK, Torre-Healy L, Vahrenkamp JM, et al
    Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4alpha and SIX1/4.
    Gut. 2020 Aug 21. pii: gutjnl-2020-321316. doi: 10.1136/gutjnl-2020-321316.
    PubMed     Abstract available
    
    
    
34. BASHA J, Lakhtakia S, Nabi Z, Pal P, et al
    Impact of disconnected pancreatic duct on recurrence of fluid collections and new-onset diabetes: do we finally have an answer?
    Gut. 2020 Aug 18. pii: gutjnl-2020-321773. doi: 10.1136/gutjnl-2020-321773.
    PubMed    
    
    
    
35. MASI AC, Oppong YEA, Haugk B, Lamb CA, et al
    Endoscopic ultrasound (EUS)-guided fine needle biopsy (FNB) formalin fixed paraffin-embedded (FFPE) pancreatic tissue samples are a potential resource for microbiota analysis.
    Gut. 2020 Aug 18. pii: gutjnl-2020-322457. doi: 10.1136/gutjnl-2020-322457.
    PubMed    
    
    
    
36. HUANG J, Chen P, Liu K, Liu J, et al
    CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
    Gut. 2020 Aug 14. pii: gutjnl-2019-320441. doi: 10.1136/gutjnl-2019-320441.
    PubMed     Abstract available
    
    
    
37. 
    Correction: STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2020;69:e5.
    PubMed    
    
    
    July 2020
38. AGHDASSI A, Tran QT, Bulla T, Bulow R, et al
    Focal pancreatic lesions in autoimmune pancreatitis and weight loss.
    Gut. 2020 Jul 22. pii: gutjnl-2020-321987. doi: 10.1136/gutjnl-2020-321987.
    PubMed    
    
    
    June 2020
39. LESINSKI GB
    Braking the cell's cycle and invigorating T-cell immunity against pancreatic cancer.
    Gut. 2020 Jun 22. pii: gutjnl-2020-321497. doi: 10.1136/gutjnl-2020-321497.
    PubMed    
    
    
    
40. GUBATAN J, Levitte S, Patel A, Balabanis T, et al
    Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.
    Gut. 2020 Jun 3. pii: gutjnl-2020-321772. doi: 10.1136/gutjnl-2020-321772.
    PubMed    
    
    
    
41. 
    Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas screening (CAPS) Consortium.
    Gut. 2020;69:e3.
    PubMed    
    
    
    May 2020
42. KNUDSEN ES, Kumarasamy V, Chung S, Ruiz A, et al
    Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer.
    Gut. 2020 May 18. pii: gutjnl-2020-321000. doi: 10.1136/gutjnl-2020-321000.
    PubMed     Abstract available
    
    
    
43. MOLINA-MONTES E, Coscia C, Gomez-Rubio P, Fernandez A, et al
    Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
    Gut. 2020 May 14. pii: gutjnl-2019-319990. doi: 10.1136/gutjnl-2019-319990.
    PubMed     Abstract available
    
    
    
44. TAKAHASHI R, Macchini M, Sunagawa M, Jiang Z, et al
    Interleukin-1beta-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression.
    Gut. 2020 May 10. pii: gutjnl-2019-319912. doi: 10.1136/gutjnl-2019-319912.
    PubMed     Abstract available
    
    
    April 2020
45. LUCHINI C, Brosens LAA, Wood LD, Chatterjee D, et al
    Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications.
    Gut. 2020 Apr 29. pii: gutjnl-2020-320726. doi: 10.1136/gutjnl-2020-320726.
    PubMed     Abstract available
    
    
    
46. TIAN J, Zhu Y, Rao M, Cai Y, et al
    N(6)-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression.
    Gut. 2020 Apr 20. pii: gutjnl-2019-320179. doi: 10.1136/gutjnl-2019-320179.
    PubMed     Abstract available
    
    
    
47. DE-MADARIA E, Sanchez-Marin C, Carrillo I, Vege SS, et al
    Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study.
    Gut. 2020 Apr 3. pii: gutjnl-2020-320729. doi: 10.1136/gutjnl-2020-320729.
    PubMed     Abstract available
    
    
    
48. HU Q, Wu J, Ren Y, Wu X, et al
    Degree of STING activation is associated with disease outcomes.
    Gut. 2020;69:792-794.
    PubMed    
    
    
    February 2020
49. BANG JY, Hawes RH, Varadarajulu S
    Lumen-apposing metal stent placement for drainage of pancreatic fluid collections: predictors of adverse events.
    Gut. 2020 Feb 17. pii: gutjnl-2019-320539. doi: 10.1136/gutjnl-2019-320539.
    PubMed    
    
    
    
50. STOLZENBERG-SOLOMON R, Derkach A, Moore S, Weinstein SJ, et al
    Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
    Gut. 2020 Feb 14. pii: gutjnl-2019-319811. doi: 10.1136/gutjnl-2019-319811.
    PubMed     Abstract available
    
    
    January 2020
51. BIEDERSTADT A, Hassan Z, Schneeweis C, Schick M, et al
    SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
    Gut. 2020 Jan 30. pii: gutjnl-2018-317856. doi: 10.1136/gutjnl-2018-317856.
    PubMed     Abstract available
    
    
    
52. WAN J, Haddock A, Edenfield B, Ji B, et al
    Transgenic expression of human PRSS2 exacerbates pancreatitis in mice.
    Gut. 2020 Jan 23. pii: gutjnl-2019-320399. doi: 10.1136/gutjnl-2019-320399.
    PubMed    
    
    
    December 2019
53. FRAMPTON AE, Giovannetti E
    Diagnosing pancreatic ductal adenocarcinoma using plasma extracellular vesicle RNA profiles.
    Gut. 2019 Dec 4. pii: gutjnl-2019-319896. doi: 10.1136/gutjnl-2019-319896.
    PubMed    
    
    
    October 2019
54. GOGGINS M, Overbeek KA, Brand R, Syngal S, et al
    Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Gut. 2019 Oct 31. pii: gutjnl-2019-319352. doi: 10.1136/gutjnl-2019-319352.
    PubMed     Abstract available
    
    
    
55. LIANG C, Shi S, Qin Y, Meng Q, et al
    Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2019 Oct 14. pii: gutjnl-2018-317163. doi: 10.1136/gutjnl-2018-317163.
    PubMed     Abstract available
    
    
    
56. TOLOSA EJ, Fernandez-Zapico ME
    Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer.
    Gut. 2019 Oct 3. pii: gutjnl-2019-318962. doi: 10.1136/gutjnl-2019-318962.
    PubMed    
    
    
    September 2019
57. YU S, Li Y, Liao Z, Wang Z, et al
    Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Gut. 2019 Sep 27. pii: gutjnl-2019-318860. doi: 10.1136/gutjnl-2019-318860.
    PubMed     Abstract available
    
    
    
58. HEGYI E, Toth AZ, Vincze A, Szentesi A, et al
    Alcohol-dependent effect of PRSS1-PRSS2 haplotype in chronic pancreatitis.
    Gut. 2019 Sep 10. pii: gutjnl-2019-319729. doi: 10.1136/gutjnl-2019-319729.
    PubMed    
    
    
    August 2019
59. HONG X, Qiao S, Li F, Wang W, et al
    Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.
    Gut. 2019 Aug 28. pii: gutjnl-2018-317233. doi: 10.1136/gutjnl-2018-317233.
    PubMed     Abstract available
    
    
    July 2019
60. NIU N, Lu P, Yang Y, He R, et al
    Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Gut. 2019 Jul 11. pii: gutjnl-2019-318362. doi: 10.1136/gutjnl-2019-318362.
    PubMed     Abstract available
    
    
    
61. BANG JY, Navaneethan U, Hasan MK, Sutton B, et al
    Non-superiority of lumen-apposing metal stents over plastic stents for drainage of walled-off necrosis in a randomised trial.
    Gut. 2019;68:1200-1209.
    PubMed     Abstract available
    
    
    June 2019
62. N KALIMUTHU S, Wilson GW, Grant RC, Seto M, et al
    Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome.
    Gut. 2019 Jun 14. pii: gutjnl-2019-318217. doi: 10.1136/gutjnl-2019-318217.
    PubMed     Abstract available
    
    
    
63. COLLET L, Ghurburrun E, Meyers N, Assi M, et al
    Kras and Lkb1 mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells.
    Gut. 2019 Jun 1. pii: gutjnl-2018-318059. doi: 10.1136/gutjnl-2018-318059.
    PubMed     Abstract available
    
    
    May 2019
64. SUN C, Liu M, An W, Mao X, et al
    Heterozygous Spink1 c.194+2T>C mutant mice spontaneously develop chronic pancreatitis.
    Gut. 2019 May 29. pii: gutjnl-2019-318790. doi: 10.1136/gutjnl-2019-318790.
    PubMed    
    
    
    
65. DREWES AM, Kempeneers MA, Andersen DK, Arendt-Nielsen L, et al
    Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons!
    Gut. 2019 May 25. pii: gutjnl-2019-318742. doi: 10.1136/gutjnl-2019-318742.
    PubMed    
    
    
    
66. JIANG H, Liu X, Knolhoff BL, Hegde S, et al
    Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion.
    Gut. 2019 May 10. pii: gutjnl-2018-317424. doi: 10.1136/gutjnl-2018-317424.
    PubMed     Abstract available
    
    
    April 2019
67. NEMETH BC, Orekhova A, Zhang W, Nortman SA, et al
    Novel p.K374E variant of CPA1 causes misfolding-induced hereditary pancreatitis with autosomal dominant inheritance.
    Gut. 2019 Apr 20. pii: gutjnl-2019-318751. doi: 10.1136/gutjnl-2019-318751.
    PubMed    
    
    
    
68. BENITZ S, Straub T, Mahajan UM, Mutter J, et al
    Ring1b-dependent epigenetic remodelling is an essential prerequisite for pancreatic carcinogenesis.
    Gut. 2019 Apr 6. pii: gutjnl-2018-317208. doi: 10.1136/gutjnl-2018-317208.
    PubMed     Abstract available
    
    
    
69. 
    Correction: Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATP.
    Gut. 2019 Apr 3. pii: gutjnl-2014-308553.
    PubMed    
    
    
    March 2019
70. HESSMANN E, Ellenrieder V
    Chromatin remodelling controls pancreatic tissue fate.
    Gut. 2019 Mar 19. pii: gutjnl-2018-317486. doi: 10.1136/gutjnl-2018-317486.
    PubMed    
    
    
    
71. GAISER RA, Halimi A, Alkharaan H, Lu L, et al
    Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.
    Gut. 2019 Mar 14. pii: gutjnl-2018-317458. doi: 10.1136/gutjnl-2018-317458.
    PubMed     Abstract available
    
    
    
72. LIN JH, Boulling A, Masson E, Cooper DN, et al
    Most unambiguous loss-of-function CPA1 mutations are unlikely to predispose to chronic pancreatitis.
    Gut. 2019 Mar 12. pii: gutjnl-2019-318564. doi: 10.1136/gutjnl-2019-318564.
    PubMed    
    
    
    
73. JIANG SH, Zhu LL, Zhang M, Li RK, et al
    GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner.
    Gut. 2019 Mar 2. pii: gutjnl-2018-317479. doi: 10.1136/gutjnl-2018-317479.
    PubMed     Abstract available
    
    
    
74. 
    Correction: Comprehensive characterisation ofcompartment-specific long non-coding RNAs associated with pancreatic ductaladenocarcinoma.
    Gut. 2019 Mar 2. pii: gutjnl-2017-314353.
    PubMed    
    
    
    February 2019
75. SINGH S, Hasselluhn MC, Neesse A
    A tangled tale of molecular subtypes in pancreatic cancer.
    Gut. 2019 Feb 27. pii: gutjnl-2018-318086. doi: 10.1136/gutjnl-2018-318086.
    PubMed    
    
    
    
76. KATO Y, Azuma K, Someda H, Shiokawa M, et al
    Case of IgG4-associated sclerosing cholangitis with normal serum IgG4 concentration, diagnosed by anti-laminin 511-E8 antibody: a novel autoantibody in patients with autoimmune pancreatitis.
    Gut. 2019 Feb 13. pii: gutjnl-2018-317934. doi: 10.1136/gutjnl-2018-317934.
    PubMed    
    
    
    
77. SHI N, Liu T, de la Iglesia-Garcia D, Deng L, et al
    Duration of organ failure impacts mortality in acute pancreatitis.
    Gut. 2019 Feb 11. pii: gutjnl-2019-318241. doi: 10.1136/gutjnl-2019-318241.
    PubMed    
    
    
    January 2019
78. ZHAO Q, Manohar M, Wei Y, Pandol SJ, et al
    STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2019 Jan 31. pii: gutjnl-2018-317098. doi: 10.1136/gutjnl-2018-317098.
    PubMed     Abstract available
    
    
    
79. MAURER HC, Holmstrom SR, He J, Laise P, et al
    Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.
    Gut. 2019 Jan 18. pii: gutjnl-2018-317706. doi: 10.1136/gutjnl-2018-317706.
    PubMed     Abstract available
    
    
    December 2018
80. BAUER CA
    Immunosuppressive betaig-h3 links tumour stroma and dysfunctional T cells in pancreatic cancer.
    Gut. 2018 Dec 7. pii: gutjnl-2018-317735. doi: 10.1136/gutjnl-2018-317735.
    PubMed    
    
    
    November 2018
81. BANG JY, Varadarajulu S
    Authors reply: treatment strategy for necrotising pancreatitis.
    Gut. 2018 Nov 17. pii: gutjnl-2018-317848. doi: 10.1136/gutjnl-2018-317848.
    PubMed    
    
    
    
82. GOEHRIG D, Nigri J, Samain R, Wu Z, et al
    Stromal protein betaig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
    Gut. 2018 Nov 10. pii: gutjnl-2018-317570. doi: 10.1136/gutjnl-2018-317570.
    PubMed     Abstract available
    
    
    
83. CONWAY JR, Herrmann D, Evans TJ, Morton JP, et al
    Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine.
    Gut. 2018 Nov 5. pii: gutjnl-2018-316822. doi: 10.1136/gutjnl-2018-316822.
    PubMed     Abstract available
    
    
    October 2018
84. LUNA J, Boni J, Cuatrecasas M, Bofill-De Ros X, et al
    DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth.
    Gut. 2018 Oct 20. pii: gutjnl-2018-316128. doi: 10.1136/gutjnl-2018-316128.
    PubMed     Abstract available
    
    
    
85. KOUTSIOUMPA M, Hatziapostolou M, Polytarchou C, Tolosa EJ, et al
    Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
    Gut. 2018 Oct 18. pii: gutjnl-2017-315690. doi: 10.1136/gutjnl-2017-315690.
    PubMed     Abstract available
    
    
    
86. WANG SC, Nassour I, Xiao S, Zhang S, et al
    SWI/SNF component ARID1A restrains pancreatic neoplasia formation.
    Gut. 2018 Oct 12. pii: gutjnl-2017-315490. doi: 10.1136/gutjnl-2017-315490.
    PubMed     Abstract available
    
    
    
87. PUPPA G, Christinat Y, McKee TA
    Towards optimal pancreatic cyst fluid management: the need for standardisation.
    Gut. 2018 Oct 9. pii: gutjnl-2018-317156. doi: 10.1136/gutjnl-2018-317156.
    PubMed    
    
    
    September 2018
88. NEESSE A, Bauer CA, Ohlund D, Lauth M, et al
    Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
    Gut. 2018 Sep 3. pii: gutjnl-2018-316451. doi: 10.1136/gutjnl-2018-316451.
    PubMed     Abstract available
    
    
    August 2018
89. RAJ D, Yang MH, Rodgers D, Hampton EN, et al
    Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma.
    Gut. 2018 Aug 18. pii: gutjnl-2018-316595. doi: 10.1136/gutjnl-2018-316595.
    PubMed     Abstract available
    
    
    
90. ROSENDAHL J
    Unfolding the mystery of digestive enzyme misfolding in chronic pancreatitis.
    Gut. 2018 Aug 3. pii: gutjnl-2018-316985. doi: 10.1136/gutjnl-2018-316985.
    PubMed    
    
    
    July 2018
91. HEGYI E, Sahin-Toth M
    Human CPA1 mutation causes digestive enzyme misfolding and chronic pancreatitis in mice.
    Gut. 2018 Jul 25. pii: gutjnl-2018-315994. doi: 10.1136/gutjnl-2018-315994.
    PubMed     Abstract available
    
    
    June 2018
92. SCHEPERS NJ, Bakker OJ, Besselink MG, Ahmed Ali U, et al
    Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis.
    Gut. 2018 Jun 27. pii: gutjnl-2017-314657. doi: 10.1136/gutjnl-2017-314657.
    PubMed     Abstract available
    
    
    May 2018
93. IKUTA K, Fukuda A, Ogawa S, Masuo K, et al
    Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice.
    Gut. 2018 May 24. pii: gutjnl-2017-315425. doi: 10.1136/gutjnl-2017-315425.
    PubMed     Abstract available
    
    
    
94. 
    Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Gut. 2018;67:994.
    PubMed    
    
    
    April 2018
95. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.
    PubMed    
    
    
    
96. ZEISSIG S, Sulk S, Brueckner S, Matthes K, et al
    Severe bleeding is a rare event in patients receiving lumen-apposing metal stents for the drainage of pancreatic fluid collections.
    Gut. 2018 Apr 20. pii: gutjnl-2018-316581. doi: 10.1136/gutjnl-2018-316581.
    PubMed    
    
    
    
97. ENEA A, Pizzol A, Pinon M, Cisaro F, et al
    Hereditary pancreatitis in Paediatrics: the causative role of p.Leu104Pro mutation of cationic trypsinogen gene also in young subjects.
    Gut. 2018 Apr 17. pii: gutjnl-2018-316443. doi: 10.1136/gutjnl-2018-316443.
    PubMed    
    
    
    
98. SCARPA A, Real FX, Luchini C
    Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316151. doi: 10.1136/gutjnl-2018-316151.
    PubMed    
    
    
    
99. HUBERS LM, Vos H, Schuurman AR, Erken R, et al
    Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
    Gut. 2018;67:728-735.
    PubMed     Abstract available
    
    
    March 2018
100. 
     European evidence-based guidelines on pancreatic cystic neoplasms.
     Gut. 2018 Mar 24. pii: gutjnl-2018-316027. doi: 10.1136/gutjnl-2018-316027.
     PubMed     Abstract available
     
     
     
101. YANG N, Li B, Pan Y, Tu J, et al
     Hypertriglyceridaemia delays pancreatic regeneration after acute pancreatitis in mice and patients.
     Gut. 2018 Mar 16. pii: gutjnl-2017-315560. doi: 10.1136/gutjnl-2017-315560.
     PubMed    
     
     
     February 2018
102. ARNES L, Liu Z, Wang J, Maurer HC, et al
     Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
     Gut. 2018 Feb 10. pii: gutjnl-2017-314353. doi: 10.1136/gutjnl-2017-314353.
     PubMed     Abstract available
     
     
     January 2018
103. LEE AYL, Dubois CL, Sarai K, Zarei S, et al
     Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
     Gut. 2018 Jan 23. pii: gutjnl-2017-314426. doi: 10.1136/gutjnl-2017-314426.
     PubMed     Abstract available
     
     
     December 2017
104. MICHL P, Krug S
     Overcoming immune evasion in pancreatic cancer: the combination matters.
     Gut. 2017 Dec 7. pii: gutjnl-2017-315443. doi: 10.1136/gutjnl-2017-315443.
     PubMed    
     
     
     
105. NYWENING TM, Belt BA, Cullinan DR, Panni RZ, et al
     Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
     Gut. 2017 Dec 1. pii: gutjnl-2017-313738. doi: 10.1136/gutjnl-2017-313738.
     PubMed     Abstract available
     
     
     
106. WU H, Boulling A, Cooper DN, Li ZS, et al
     In vitro and in silico evidence against a significant effect of the SPINK1 c.194G>A variant on pre-mRNA splicing.
     Gut. 2017;66:2195-2196.
     PubMed    
     
     
     November 2017
107. HUANG L, Jansen L, Balavarca Y, Molina-Montes E, et al
     Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.
     Gut. 2017 Nov 20. pii: gutjnl-2017-314828. doi: 10.1136/gutjnl-2017-314828.
     PubMed     Abstract available
     
     
     October 2017
108. CHOU A, Froio D, Nagrial AM, Parkin A, et al
     Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.
     Gut. 2017 Oct 28. pii: gutjnl-2017-315144. doi: 10.1136/gutjnl-2017-315144.
     PubMed     Abstract available
     
     
     
109. NOTTA F, Hahn SA, Real FX
     A genetic roadmap of pancreatic cancer: still evolving.
     Gut. 2017 Oct 9. pii: gutjnl-2016-313317. doi: 10.1136/gutjnl-2016-313317.
     PubMed     Abstract available
     
     
     
110. BANG JY, Hebert-Magee S, Navaneethan U, Hasan MK, et al
     EUS-guided fine needle biopsy of pancreatic masses can yield true histology: results of a randomised trial.
     Gut. 2017 Oct 7. pii: gutjnl-2017-315154. doi: 10.1136/gutjnl-2017-315154.
     PubMed    
     
     
     September 2017
111. SINGHI AD, McGrath K, Brand RE, Khalid A, et al
     Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
     Gut. 2017 Sep 28. pii: gutjnl-2016-313586. doi: 10.1136/gutjnl-2016-313586.
     PubMed     Abstract available
     
     
     
112. TANG XY, Zou WB, Masson E, Hu LH, et al
     The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.
     Gut. 2017 Sep 26. pii: gutjnl-2017-315180. doi: 10.1136/gutjnl-2017-315180.
     PubMed    
     
     
     
113. HOPPER AD, Campbell JA
     Improving future studies in chronic pancreatitis: a paradigm shift in our understanding?
     Gut. 2017 Sep 22. pii: gutjnl-2017-315067. doi: 10.1136/gutjnl-2017-315067.
     PubMed    
     
     
     
114. KROMREY ML, Bulow R, Hubner J, Paperlein C, et al
     Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study.
     Gut. 2017 Sep 6. pii: gutjnl-2016-313127. doi: 10.1136/gutjnl-2016-313127.
     PubMed     Abstract available
     
     
     August 2017
115. VAN DIJK SM, Hallensleben NDL, van Santvoort HC, Fockens P, et al
     Acute pancreatitis: recent advances through randomised trials.
     Gut. 2017 Aug 24. pii: gutjnl-2016-313595. doi: 10.1136/gutjnl-2016-313595.
     PubMed     Abstract available
     
     
     
116. IORIO V, Rosati A, D'Auria R, De Marco M, et al
     Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8+ T cell number and tumour growth in pancreatic cancer.
     Gut. 2017 Aug 11. pii: gutjnl-2017-314225. doi: 10.1136/gutjnl-2017-314225.
     PubMed    
     
     
     
117. SARR MG
     Minimal access necrosectomy: the newest advance of many in the treatment of necrotising pancreatitis.
     Gut. 2017 Aug 10. pii: gutjnl-2017-314660. doi: 10.1136/gutjnl-2017-314660.
     PubMed    
     
     
     
118. SELEZNIK GM, Reding T, Peter L, Gupta A, et al
     Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation.
     Gut. 2017 Aug 3. pii: gutjnl-2016-313458. doi: 10.1136/gutjnl-2016-313458.
     PubMed     Abstract available
     
     
     
119. VAN BRUNSCHOT S, Hollemans RA, Bakker OJ, Besselink MG, et al
     Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients.
     Gut. 2017 Aug 3. pii: gutjnl-2016-313341. doi: 10.1136/gutjnl-2016-313341.
     PubMed     Abstract available
     
     
     
120. SINGH VP
     High on drugs: lessons from opiates in pancreatitis.
     Gut. 2017 Aug 1. pii: gutjnl-2017-314506. doi: 10.1136/gutjnl-2017-314506.
     PubMed    
     
     
     July 2017
121. ROSENDAHL J, Kirsten H, Hegyi E, Kovacs P, et al
     Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.
     Gut. 2017 Jul 28. pii: gutjnl-2017-314454. doi: 10.1136/gutjnl-2017-314454.
     PubMed     Abstract available
     
     
     June 2017
122. SCARPA A, Mafficini A
     Non-coding regulatory variations: the dark matter of pancreatic cancer genomics.
     Gut. 2017 Jun 28. pii: gutjnl-2017-314310. doi: 10.1136/gutjnl-2017-314310.
     PubMed    
     
     
     
123. BARLASS U, Dutta R, Cheema H, George J, et al
     Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis.
     Gut. 2017 Jun 22. pii: gutjnl-2017-313717. doi: 10.1136/gutjnl-2017-313717.
     PubMed     Abstract available
     
     
     
124. ZHANG M, Lykke-Andersen S, Zhu B, Xiao W, et al
     Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.
     Gut. 2017 Jun 20. pii: gutjnl-2016-313146. doi: 10.1136/gutjnl-2016-313146.
     PubMed     Abstract available
     
     
     
125. GOYAL J, Barkin JA, Barkin JS
     Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis.
     Gut. 2017 Jun 10. pii: gutjnl-2017-314460. doi: 10.1136/gutjnl-2017-314460.
     PubMed    
     
     
     
126. MASSON E, Chen JM, Cooper DN, Ferec C, et al
     PRSS1 copy number variants and promoter polymorphisms in pancreatitis: common pathogenetic mechanism, different genetic effects.
     Gut. 2017 Jun 10. pii: gutjnl-2017-314443. doi: 10.1136/gutjnl-2017-314443.
     PubMed    
     
     
     May 2017
127. COSTELLO E
     A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis.
     Gut. 2017 May 24. pii: gutjnl-2016-313665. doi: 10.1136/gutjnl-2016-313665.
     PubMed    
     
     
     March 2017
128. ZHU H, Lin H, Jin Z, Du Y, et al
     Re-evaluation of the role of lumen-apposing metal stents (LAMS) for pancreatic fl uid collection drainage.
     Gut. 2017 Mar 17. pii: gutjnl-2017-313949. doi: 10.1136/gutjnl-2017-313949.
     PubMed    
     
     
     
129. KUJKO AA, Berki DM, Oracz G, Wejnarska K, et al
     A novel p.Ser282Pro CPA1 variant is associated with autosomal dominant hereditary pancreatitis.
     Gut. 2017 Mar 3. pii: gutjnl-2017-313816. doi: 10.1136/gutjnl-2017-313816.
     PubMed    
     
     
     February 2017
130. SANCHEZ-AREVALO LOBO VJ, Fernandez LC, Carrillo-de-Santa-Pau E, Richart L, et al
     c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis.
     Gut. 2017 Feb 3. pii: gutjnl-2016-312306. doi: 10.1136/gutjnl-2016-312306.
     PubMed     Abstract available
     
     
     January 2017
131. WINDSOR JA
     Pancreatic enzyme replacement therapy in chronic pancreatitis: a long way to go.
     Gut. 2017 Jan 27. pii: gutjnl-2016-313455. doi: 10.1136/gutjnl-2016-313455.
     PubMed    
     
     
     
132. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
     Updated guideline on the management of common bile duct stones (CBDS).
     Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
     PubMed     Abstract available
     
     
     
133. MAYERLE J, Kalthoff H, Reszka R, Kamlage B, et al
     Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
     Gut. 2017 Jan 20. pii: gutjnl-2016-312432. doi: 10.1136/gutjnl-2016-312432.
     PubMed     Abstract available
     
     
     
134. STECHER SS, Simon P, Friesecke S, Glitsch A, et al
     Delayed severe bleeding complications after treatment of pancreatic fluid collections with lumen-apposing metal stents.
     Gut. 2017 Jan 12. pii: gutjnl-2016-313562. doi: 10.1136/gutjnl-2016-313562.
     PubMed    
     
     
     
135. KNUDSEN ES, Balaji U, Mannakee B, Vail P, et al
     Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.
     Gut. 2017 Jan 10. pii: gutjnl-2016-313133. doi: 10.1136/gutjnl-2016-313133.
     PubMed     Abstract available
     
     
     December 2016
136. NEMETH BC, Patai AV, Sahin-Toth M, Hegyi P, et al
     Misfolding cationic trypsinogen variant p.L104P causes hereditary pancreatitis.
     Gut. 2016 Dec 23. pii: gutjnl-2016-313451. doi: 10.1136/gutjnl-2016-313451.
     PubMed    
     
     
     
137. RYAN BM, Venkatachalapathy SV, Huggett MT
     Safety of lumen-apposing metal stents (LAMS) for pancreatic fluid collection drainage.
     Gut. 2016 Dec 16. pii: gutjnl-2016-313388. doi: 10.1136/gutjnl-2016-313388.
     PubMed    
     
     
     
138. DE LA IGLESIA-GARCIA D, Huang W, Szatmary P, Baston-Rey I, et al
     Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
     Gut. 2016 Dec 9. pii: gutjnl-2016-312529. doi: 10.1136/gutjnl-2016-312529.
     PubMed     Abstract available
     
     
     
139. DUELL EJ
     Telomere length and pancreatic cancer risk: breaking down the evidence.
     Gut. 2016 Dec 5. pii: gutjnl-2016-313156. doi: 10.1136/gutjnl-2016-313156.
     PubMed    
     
     
     November 2016
140. TEICH N, Bokemeyer B, Mohl W, Walldorf J, et al
     Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.
     Gut. 2016 Nov 14. pii: gutjnl-2016-313138. doi: 10.1136/gutjnl-2016-313138.
     PubMed    
     
     
     
141. LEEDS JS, Nayar MK, Charnley RM, Oppong KW, et al
     Lumen-apposing metal stents for pancreatic fluid collection drainage: may not be business as usual?
     Gut. 2016 Nov 4. pii: gutjnl-2016-313187. doi: 10.1136/gutjnl-2016-313187.
     PubMed    
     
     
     
142. HESSMANN E, Johnsen SA, Siveke JT, Ellenrieder V, et al
     Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
     Gut. 2016 Nov 3. pii: gutjnl-2016-312539. doi: 10.1136/gutjnl-2016-312539.
     PubMed     Abstract available
     
     
     October 2016
143. BAO Y, Prescott J, Yuan C, Zhang M, et al
     Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer.
     Gut. 2016 Oct 21. pii: gutjnl-2016-312510. doi: 10.1136/gutjnl-2016-312510.
     PubMed     Abstract available
     
     
     
144. MACE TA, Shakya R, Pitarresi JR, Swanson B, et al
     IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
     Gut. 2016 Oct 21. pii: gutjnl-2016-311585. doi: 10.1136/gutjnl-2016-311585.
     PubMed     Abstract available
     
     
     
145. FAN X, Alekseyenko AV, Wu J, Peters BA, et al
     Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.
     Gut. 2016 Oct 14. pii: gutjnl-2016-312580. doi: 10.1136/gutjnl-2016-312580.
     PubMed     Abstract available
     
     
     
146. HART PA, Chari ST
     Preventing disease relapses in autoimmune pancreatitis with maintenance steroids: are we there yet?
     Gut. 2016 Oct 5. pii: gutjnl-2016-312738. doi: 10.1136/gutjnl-2016-312738.
     PubMed    
     
     
     September 2016
147. WILLS ES, Drenth JP
     Building pancreatic organoids to aid drug development.
     Gut. 2016 Sep 21. pii: gutjnl-2016-312865. doi: 10.1136/gutjnl-2016-312865.
     PubMed    
     
     
     
148. KONG B, Bruns P, Behler NA, Chang L, et al
     Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy.
     Gut. 2016 Sep 19. pii: gutjnl-2015-310913. doi: 10.1136/gutjnl-2015-310913.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: